@article{3078936,
    title = "Response to: Comment on ‘Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines’",
    author = "Peris, K. and Fargnoli, M.C. and Garbe, C. and Kaufmann, R. and Bastholt, L. and Seguin, N.B. and Bataille, V. and del Marmol, V. and Dummer, R. and Harwood, C.A. and Hauschild, A. and Höller, C. and Haedersdal, M. and Malvehy, J. and Middleton, M.R. and Morton, C.A. and Nagore, E. and Stratigos, A.J. and Szeimies, R.-M. and Tagliaferri, L. and Trakatelli, M. and Zalaudek, I. and Eggermont, A. and Grob, J.J. and the European Dermatology Forum (EDF) and the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC)",
    journal = "EUROPEAN JOURNAL OF CANCER",
    year = "2020",
    volume = "140",
    pages = "154-157",
    publisher = "Elsevier Ireland Ltd",
    doi = "10.1016/j.ejca.2020.08.006",
    keywords = "antineoplastic agent, advanced cancer;  algorithm;  basal cell carcinoma;  cancer control;  cancer diagnosis;  cancer palliative therapy;  cancer recurrence;  cancer therapy;  clinical effectiveness;  clinical practice;  consensus;  electrochemotherapy;  Europe;  follow up;  human;  Kaposi sarcoma;  Letter;  merkel cell carcinoma;  multicenter study (topic);  observational study;  practice guideline;  priority journal;  prospective study;  recurrence risk;  retrospective study;  soft tissue sarcoma;  treatment response;  tumor volume;  basal cell carcinoma;  skin tumor, Carcinoma, Basal Cell;  Consensus;  Humans;  Skin Neoplasms"
}